(1211-D) Advancing Antibody Discovery with OmniAb: High-Throughput Screening with xPloration™
Tuesday, February 6, 2024
2:00 PM – 3:00 PM EST
Location: Exhibit Halls AB
Abstract: OmniAb provides our partners robust custom antibody libraries through its transgenic animal platforms. The OmniAb platform employs xPloration™, a cutting-edge technology designed for drug discovery, which facilitates the high-throughput and high-content, machine vision-based screening of millions of antibody-secreting cells. This versatile microcapillary array technology supports a multitude of assay formats. Coupled with Next-Generation Sequencing (NGS), xPloration enables comprehensive profiling of immune repertoires on a large scale.